Erez Chimovits Buys 825,000 Shares of Upstream Bio, Inc. (NASDAQ:UPB) Stock

Upstream Bio, Inc. (NASDAQ:UPB) Director Erez Chimovits bought 825,000 shares of Upstream Bio stock in a transaction on Tuesday, October 15th. The shares were acquired at an average cost of $17.00 per share, for a total transaction of $14,025,000.00. Following the completion of the acquisition, the director now directly owns 4,554,873 shares in the company, valued at approximately $77,432,841. The trade was a 0.00 % increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website.

Upstream Bio Stock Performance

Shares of Upstream Bio stock opened at $25.88 on Friday. Upstream Bio, Inc. has a twelve month low of $20.74 and a twelve month high of $26.88.

Upstream Bio Company Profile

Upstream Bio, Inc, a clinical-stage biotechnology company, develops treatments for inflammatory diseases that focuses on severe respiratory disorders. It develops verekitug, a monoclonal antibody that targets and inhibits the thymic stromal lymphopoietin receptor. The company also develops therapies to treat severe asthma, chronic rhinosinusitis with nasal polyps, and chronic obstructive pulmonary disease.